3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
667
Neoplasms
588
Colorectal Neoplasms
291
Carcinoma, Non-Small-Cell Lung
289
Prostatic Neoplasms
278
Lung Neoplasms
218
Melanoma
160
Multiple Myeloma
149
Neoplasm Metastasis
145
Head and Neck Neoplasms
143
Pancreatic Neoplasms
140
Ovarian Neoplasms
129
Carcinoma, Hepatocellular
126
Leukemia, Myeloid, Acute
121
Brain Neoplasms
112
Squamous Cell Carcinoma of Head and Neck
109
Colonic Neoplasms
109
Uterine Cervical Neoplasms
107
Stomach Neoplasms
102
Recurrence
101
Lymphoma
100
Glioblastoma
91
Lymphoma, Non-Hodgkin
82
Hematologic Neoplasms
79
Precursor Cell Lymphoblastic Leukemia-Lymphoma
78
Lymphoma, Follicular
77
Urinary Bladder Neoplasms
76
Parkinson Disease 4, Autosomal Dominant Lewy Body
74
Glioma
73
Carcinoma, Renal Cell
71
Interventions
Triamcinolone Acetonide
1
Injections, Intramuscular
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Castration Resistant Prostate Cancer
×
1 year
×
Clear all
NCT07161778
2025-09-09
TRICREST
Barts & The London NHS Trust
Phase 2
Completed
55 enrolled